Publication:
Influenza AH1N1 2009 pneumonia in kidney transplant recipients: Characteristics and outcomes following high-dose oseltamivir exposure

dc.contributor.authorS. P. Watcharanananen_US
dc.contributor.authorT. Suwatanapongcheden_US
dc.contributor.authorP. Wacharawanichkulen_US
dc.contributor.authorW. Chantratitayaen_US
dc.contributor.authorV. Mavichaken_US
dc.contributor.authorS. B. Mossaden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherPraram 9 Hospitalen_US
dc.contributor.otherCleveland Clinic Foundationen_US
dc.date.accessioned2018-09-24T09:30:44Z
dc.date.available2018-09-24T09:30:44Z
dc.date.issued2010-04-01en_US
dc.description.abstractWe report 2 cases of severe pneumonia due to the novel pandemic influenza AH1N1 2009 in kidney transplant recipients. Our patients initially experienced influenza-like illness that rapidly progressed to severe pneumonia within 48 h. The patients became hypoxic and required non-invasive ventilation. The novel influenza AH1N1 2009 was identified from their nasal swabs. These cases were treated successfully with a relatively high dose of oseltamivir, adjusted for their renal function. Clinical improvement was documented only after a week of antiviral therapy. Despite early antiviral treatment, we showed that morbidity following novel pandemic influenza AH1N1 2009 infection is high among kidney transplant recipients. © 2010 John Wiley & Sons A/S.en_US
dc.identifier.citationTransplant Infectious Disease. Vol.12, No.2 (2010), 127-131en_US
dc.identifier.doi10.1111/j.1399-3062.2010.00493.xen_US
dc.identifier.issn13993062en_US
dc.identifier.issn13982273en_US
dc.identifier.other2-s2.0-77950555049en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/29718
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77950555049&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleInfluenza AH1N1 2009 pneumonia in kidney transplant recipients: Characteristics and outcomes following high-dose oseltamivir exposureen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77950555049&origin=inwarden_US

Files

Collections